Cancer Gene Therapy Market Size, Share, Industry, Forecast and Outlook (2024-2031)

<h2>Global Cancer Gene Therapy Market&nbsp;is segmented By Technique (In vivo Gene Therapy, Ex vivo Gene Therapy)&nbsp;By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer, Others) By Application (Brain Cancer, Lung Cancer, Breast Cancer, Pancreatic Cancer, Liver Cancer, Others) By End-User (Hospitals, Cancer Centers, Others)&nbsp;and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2024-2031</h2>

<h3>Market Overview</h3>

<blockquote>
Global Cancer Gene Therapy market reached US$ YY&nbsp;million in 2023 and is expected to reach US$ YY&nbsp;million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.
</blockquote>

Cancer gene therapy is a promising field of medicine that uses genetic modification to treat cancer. It includes inserting genetic material into cancer cells to either directly kill them or increase their susceptibility to the immune system of the body. A vital tool for cancer researchers and physicians is cancer gene therapy, which includes cellular and gene therapies.&nbsp;

By directly killing cells, modulating the immune system, or fixing genetic defects to reverse the malignant state, nucleic acids can be transferred into the tumor or normal cells in cancer gene therapy to eradicate or minimize the tumor burden.

<h3>Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #8eaadb; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			YY%
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Size Available for Years
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2022-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Estimation Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2024-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Revenue Units
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$ Mn)&nbsp;
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Technique, Therapy, Application, End-User
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America, and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For more details on this report &ndash; <a href="https://www.datamintelligence.com/download-sample/cancer-gene-therapy-market" target="_blank">Request for Sample</a>

<h3>&nbsp;</h3>

<h3>Market Dynamics: Drivers &amp; Restraints</h3>

Rising burden of cancer cases

The increasing cancer burden is expected to drive the market growth. The rising number of cancer cases is elevating and expanding the research and developmental activities. The rising prevalence of cancer also fuels the trend towards personalized medicine. A larger pool of potential patients with cancer creates a greater market opportunity for companies developing gene therapies. Gene therapy is a promising new method for treating non-small cell lung cancer.&nbsp;

For instance, according to the report published by the American Society of Cancer in 2024, it is estimated that lung cancer is the second most common cancer in both men and women in the United States.&nbsp;

Additionally, according to the report by the World Health Organization in 2022, it is estimated that around 2.3 million women are diagnosed with breast cancer and 670,000 deaths globally. Among women, breast cancer can strike at any age after adolescence and is more common in later life. Thus, the above factors are expected to drive the market growth.&nbsp;

High developmental and treatment costs&nbsp;&nbsp;

Gene therapy development and production is a costly and intricate procedure. This leads to heavy treatment costs, which could prevent many people from receiving it and put pressure on healthcare finances. The widespread adoption of these expensive medicines may be restricted by the reluctance of government programs, insurance providers, and hospitals to pay for them.

<h3>Segment Analysis</h3>

The global cancer gene therapy market is segmented based on technique, therapy, application, end-user and region.

Gene Induced Immunotherapy (GII) segment is expected to dominate the market growth

Gene induced immunotherapy segment is expected to hold the dominant position in the market share. This is due to the advantages of the procedure over other types. GII has the potential to be highly specific. By altering a patient&#39;s own immune cells to specifically target cancer antigens, gene-editing immunotherapy (GII)&nbsp;reduces the adverse effects associated with conventional medicines that could damage healthy cells.

GII provides a means of potentially eliciting a durable immune response against cancerous cells. Engineered immune cells can persist in the body and keep attacking cancer cells, potentially leading to durable remissions or even cures. GII medicines could be produced for different forms of cancer by targeting different antigens or by employing different gene editing techniques. Thus, the above factors are expected to drive the segment growth in the forecast period.

<h3>Geographical Analysis</h3>

North America is expected to hold a significant position in the cancer gene therapy market share

North America is expected to hold the dominant position in the market share. The region has a long history of substantial support for medical research, including studies on cancer. The National Cancer Institute (NCI) and other organizations are essential in providing financing and assistance for gene therapy research and development (R&amp;D). North America&#39;s standing is further enhanced by the presence of notable institutions and research facilities.

For instance, according to the National Center for Science and Engineering Statistics in 2022, research and development spending by academic institutions totaled $97.8 billion in FY 2022, an increase of $8.0 billion from FY 2021. R&amp;D expenditures funded by federal sources accounted for $4.9 billion of the total increase. Thus, increasing investments, funds and improved treatment options are expected to drive the region&rsquo;s market growth.

<h3>COVID-19 Impact Analysis</h3>

During the early phases of the pandemic, numerous clinical trials for cancer gene therapy were postponed and discontinued. This was due to concerns about patient safety and the need to reallocate resources towards COVID-19 care. Approval and development of new gene therapies are slowed down by these hurdles. Research on COVID-19 &nbsp;has received funding that was intended for cancer research, including gene therapy.&nbsp;

<h3>Competitive Landscape</h3>

The major global players in the market include Novartis AG, Gilead Sciences, Inc., Editas Medicine, Transgene SA, Amgen Inc., Sorrento Therapeutics, Inc., BioNTech SE., Cellectis, ALLOGENE THERAPEUTICS, Cabaletta Bio, Inc. among others.

<h3>Why Purchase the Report?</h3>

<ul>
	<li>To visualize the global cancer gene therapy market segmentation based on technique, therapy, application, end-user and region as well as understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>Excel data sheet with numerous data points of cancer gene therapy market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global cancer gene therapy market report would provide approximately 53 tables, 47 figures and 176 pages.

<h3>Target Audience 2024</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Technique</li>
		<li>Snippet by Therapy</li>
		<li>Snippet by Application</li>
		<li>Snippet by End-User</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Rising burden of cancer cases</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>High developmental and treatment costs&nbsp;</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Reimbursement Analysis</li>
		<li>Patent Analysis</li>
		<li>SWOT Analysis</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Technique</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique</li>
			<li>Market Attractiveness Index, By Technique</li>
		</ol>
		</li>
		<li>In vivo Gene Therapy*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Ex vivo Gene Therapy</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Therapy</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy</li>
			<li>Market Attractiveness Index, By Therapy</li>
		</ol>
		</li>
		<li>Gene Induced Immunotherapy*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Oncolytic Virotherapy</li>
		<li>Gene Transfer</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Application</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Attractiveness Index, By Application</li>
		</ol>
		</li>
		<li>Brain Cancer*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Lung Cancer</li>
		<li>Breast Cancer</li>
		<li>Pancreatic Cancer&nbsp;</li>
		<li>Liver Cancer&nbsp;</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By End-User</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Attractiveness Index, By End-User</li>
		</ol>
		</li>
		<li>Hospitals &amp; Clinics *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Cancer Centers</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			</ol>
			</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			</ol>
			</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			</ol>
			</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			</ol>
			</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics
			<ol>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy</li>
				<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			</ol>
			</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>Novartis AG*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>Gilead Sciences, Inc.&nbsp;</li>
		<li>Editas Medicine&nbsp;</li>
		<li>Transgene SA&nbsp;</li>
		<li>Amgen Inc.</li>
		<li>Sorrento Therapeutics, Inc.&nbsp;</li>
		<li>BioNTech SE.&nbsp;</li>
		<li>Cellectis</li>
		<li>ALLOGENE THERAPEUTICS&nbsp;</li>
		<li>Cabaletta Bio, Inc.&nbsp;&nbsp;(LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table 1 Global Cancer Gene Therapy Market Value, By Technique, 2023, 2027 &amp; 2031 (US$ Million)

Table 2 Global Cancer Gene Therapy Market Value, By Therapy, 2023, 2027 &amp; 2031 (US$ Million)

Table 3 Global Cancer Gene Therapy Market Value, By Application, 2023, 2027 &amp; 2031 (US$ Million)

Table 4 Global Cancer Gene Therapy Market Value, By End-User, 2023, 2027 &amp; 2031 (US$ Million)

Table 5 Global Cancer Gene Therapy Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 6 Global Cancer Gene Therapy Market Value, By Technique, 2023, 2027 &amp; 2031 (US$ Million)

Table 7 Global Cancer Gene Therapy Market Value, By Technique, 2022-2031 (US$ Million)

Table 8 Global Cancer Gene Therapy Market Value, By Therapy, 2023, 2027 &amp; 2031 (US$ Million)

Table 9 Global Cancer Gene Therapy Market Value, By Therapy, 2022-2031 (US$ Million)

Table 10 Global Cancer Gene Therapy Market Value, By Application, 2023, 2027 &amp; 2031 (US$ Million)

Table 11 Global Cancer Gene Therapy Market Value, By Application, 2022-2031 (US$ Million)

Table 12 Global Cancer Gene Therapy Market Value, By End-User, 2023, 2027 &amp; 2031 (US$ Million)

Table 13 Global Cancer Gene Therapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 14 Global Cancer Gene Therapy Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 15 Global Cancer Gene Therapy Market Value, By Region, 2022-2031 (US$ Million)

Table 16 North America Cancer Gene Therapy Market Value, By Technique, 2022-2031 (US$ Million)

Table 17 North America Cancer Gene Therapy Market Value, By Therapy, 2022-2031 (US$ Million)

Table 18 North America Cancer Gene Therapy Market Value, By Application, 2022-2031 (US$ Million)

Table 19 North America Cancer Gene Therapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 20 North America Cancer Gene Therapy Market Value, By Country, 2022-2031 (US$ Million)

Table 21 South America Cancer Gene Therapy Market Value, By Technique, 2022-2031 (US$ Million)

Table 22 South America Cancer Gene Therapy Market Value, By Therapy, 2022-2031 (US$ Million)

Table 23 South America Cancer Gene Therapy Market Value, By Application, 2022-2031 (US$ Million)

Table 24 South America Cancer Gene Therapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 25 South America Cancer Gene Therapy Market Value, By Country, 2022-2031 (US$ Million)

Table 26 Europe Cancer Gene Therapy Market Value, By Technique, 2022-2031 (US$ Million)

Table 27 Europe Cancer Gene Therapy Market Value, By Therapy, 2022-2031 (US$ Million)

Table 28 Europe Cancer Gene Therapy Market Value, By Application, 2022-2031 (US$ Million)

Table 29 Europe Cancer Gene Therapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 30 Europe Cancer Gene Therapy Market Value, By Country, 2022-2031 (US$ Million)

Table 31 Asia-Pacific Cancer Gene Therapy Market Value, By Technique, 2022-2031 (US$ Million)

Table 32 Asia-Pacific Cancer Gene Therapy Market Value, By Therapy, 2022-2031 (US$ Million)

Table 33 Asia-Pacific Cancer Gene Therapy Market Value, By Application, 2022-2031 (US$ Million)

Table 34 Asia-Pacific Cancer Gene Therapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 35 Asia-Pacific Cancer Gene Therapy Market Value, By Country, 2022-2031 (US$ Million)

Table 36 Middle East &amp; Africa Cancer Gene Therapy Market Value, By Technique, 2022-2031 (US$ Million)

Table 37 Middle East &amp; Africa Cancer Gene Therapy Market Value, By Therapy, 2022-2031 (US$ Million)

Table 38 Middle East &amp; Africa Cancer Gene Therapy Market Value, By Application, 2022-2031 (US$ Million)

Table 39 Middle East &amp; Africa Cancer Gene Therapy Market Value, By End-User, 2022-2031 (US$ Million)

Table 40 Novartis AG : Overview

Table 41 Novartis AG : Product Portfolio

Table 42 Novartis AG : Key Developments

Table 43 Gilead Sciences, Inc. : Overview

Table 44 Gilead Sciences, Inc. : Product Portfolio

Table 45 Gilead Sciences, Inc. : Key Developments

Table 46 Editas Medicine : Overview

Table 47 Editas Medicine : Product Portfolio

Table 48 Editas Medicine : Key Developments

Table 49 Transgene SA : Overview

Table 50 Transgene SA : Product Portfolio

Table 51 Transgene SA : Key Developments

Table 52 Amgen Inc.: Overview

Table 53 Amgen Inc.: Product Portfolio

Table 54 Amgen Inc.: Key Developments

Table 55 Sorrento Therapeutics, Inc. : Overview

Table 56 Sorrento Therapeutics, Inc. : Product Portfolio

Table 57 Sorrento Therapeutics, Inc. : Key Developments

Table 58 BioNTech SE. : Overview

Table 59 BioNTech SE. : Product Portfolio

Table 60 BioNTech SE. : Key Developments

Table 61 Cellectis: Overview

Table 62 Cellectis: Product Portfolio

Table 63 Cellectis: Key Developments

Table 64 ALLOGENE THERAPEUTICS : Overview

Table 65 ALLOGENE THERAPEUTICS : Product Portfolio

Table 66 ALLOGENE THERAPEUTICS : Key Developments

Table 67 Cabaletta Bio, Inc.: Overview

Table 68 Cabaletta Bio, Inc.: Product Portfolio

Table 69 Cabaletta Bio, Inc.: Key Developments

List of Figures

Figure 1 Global Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 2 Global Cancer Gene Therapy Market Share, By Technique, 2023 &amp; 2031 (%)

Figure 3 Global Cancer Gene Therapy Market Share, By Therapy, 2023 &amp; 2031 (%)

Figure 4 Global Cancer Gene Therapy Market Share, By Application, 2023 &amp; 2031 (%)

Figure 5 Global Cancer Gene Therapy Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 6 Global Cancer Gene Therapy Market Share, By Region, 2023 &amp; 2031 (%)

Figure 7 Global Cancer Gene Therapy Market Y-o-Y Growth, By Technique, 2023-2031 (%)

Figure 8 In vivo Gene Therapy Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 9 Ex vivo Gene Therapy Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 10 Global Cancer Gene Therapy Market Y-o-Y Growth, By Therapy, 2023-2031 (%)

Figure 11 Gene Induced Immunotherapy Therapy in Global Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 12 Oncolytic Virotherapy Therapy in Global Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 13 Gene Transfer Therapy in Global Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 14 Others Therapy in Global Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 15 Global Cancer Gene Therapy Market Y-o-Y Growth, By Application, 2023-2031 (%)

Figure 16 Brain Cancer&nbsp; Application in Global Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 17 Lung Cancer Application in Global Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 18 Breast Cancer Application in Global Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 19 Pancreatic Cancer&nbsp; Application in Global Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 20 Liver Cancer&nbsp; Application in Global Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 21 Others Application in Global Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 22 Global Cancer Gene Therapy Market Y-o-Y Growth, By End-User, 2023-2031 (%)

Figure 23 Hospitals &amp; Clinics End-User in Global Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 24 Cancer Centers End-User in Global Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 25 Others End-User in Global Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 26 Global Cancer Gene Therapy Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 27 North America Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 28 Asia-Pacific Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 29 Europe Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 30 South America Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 31 Middle East and Africa Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 32 North America Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 33 North America Cancer Gene Therapy Market Share, By Technique, 2023 &amp; 2031 (%)

Figure 34 North America Cancer Gene Therapy Market Share, By Therapy, 2023 &amp; 2031 (%)

Figure 35 North America Cancer Gene Therapy Market Share, By Application, 2023 &amp; 2031 (%)

Figure 36 North America Cancer Gene Therapy Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 37 North America Cancer Gene Therapy Market Share, By Country, 2023 &amp; 2031 (%)

Figure 38 South America Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 39 South America Cancer Gene Therapy Market Share, By Technique, 2023 &amp; 2031 (%)

Figure 40 South America Cancer Gene Therapy Market Share, By Therapy, 2023 &amp; 2031 (%)

Figure 41 South America Cancer Gene Therapy Market Share, By Application, 2023 &amp; 2031 (%)

Figure 42 South America Cancer Gene Therapy Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 43 South America Cancer Gene Therapy Market Share, By Country, 2023 &amp; 2031 (%)

Figure 44 Europe Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 45 Europe Cancer Gene Therapy Market Share, By Technique, 2023 &amp; 2031 (%)

Figure 46 Europe Cancer Gene Therapy Market Share, By Therapy, 2023 &amp; 2031 (%)

Figure 47 Europe Cancer Gene Therapy Market Share, By Application, 2023 &amp; 2031 (%)

Figure 48 Europe Cancer Gene Therapy Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 49 Europe Cancer Gene Therapy Market Share, By Country, 2023 &amp; 2031 (%)

Figure 50 Asia-Pacific Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 51 Asia-Pacific Cancer Gene Therapy Market Share, By Technique, 2023 &amp; 2031 (%)

Figure 52 Asia-Pacific Cancer Gene Therapy Market Share, By Therapy, 2023 &amp; 2031 (%)

Figure 53 Asia-Pacific Cancer Gene Therapy Market Share, By Application, 2023 &amp; 2031 (%)

Figure 54 Asia-Pacific Cancer Gene Therapy Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 55 Asia-Pacific Cancer Gene Therapy Market Share, By Country, 2023 &amp; 2031 (%)

Figure 56 Middle East &amp; Africa Cancer Gene Therapy Market Value, 2022-2031 (US$ Million)

Figure 57 Middle East &amp; Africa Cancer Gene Therapy Market Share, By Technique, 2023 &amp; 2031 (%)

Figure 58 Middle East &amp; Africa Cancer Gene Therapy Market Share, By Therapy, 2023 &amp; 2031 (%)

Figure 59 Middle East &amp; Africa Cancer Gene Therapy Market Share, By Application, 2023 &amp; 2031 (%)

Figure 60 Middle East &amp; Africa Cancer Gene Therapy Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 61 Novartis AG : Financials

Figure 62 Gilead Sciences, Inc. : Financials

Figure 63 Editas Medicine : Financials

Figure 64 Transgene SA : Financials

Figure 65 Amgen Inc.: Financials

Figure 66 Sorrento Therapeutics, Inc. : Financials

Figure 67 BioNTech SE. : Financials

Figure 68 Cellectis: Financials

Figure 69 ALLOGENE THERAPEUTICS : Financials

Figure 70 Cabaletta Bio, Inc.: Financials

Cancer Gene Therapy Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Cell Isolation Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 May 16

Starting from

Cell Therapy Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 January 11

Starting from

Gene Therapy Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 January 10

Starting from